Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Trauma-Informed Care for Genital Skin Diseases in Transgender Patients

Description

The talk focused on trauma-informed, affirming care for genital skin diseases in transgender patients, emphasizing that sex, gender identity, expression, orientation, and behavior are multidimensional and should be routinely and respectfully discussed. The speaker highlighted common barriers to care, including stigma, prior discrimination, misgendering, and high rates of trauma, abuse, and homelessness among transgender people, which can make genital exams distressing. Practical guidance included preparing in advance using EHR data, asking permission throughout the visit, offering choices about chaperones and support people, staying in the patient’s line of sight, avoiding triggering language, checking for nonverbal distress, and letting the patient decide whether and when an exam happens. The lecture reviewed anatomy after gender-affirming surgery, including penile-inversion and colonic vaginoplasty and phalloplasty, and presented examples of common complications such as allergic contact dermatitis to topical agents, lichen sclerosus, HPV/condyloma, irritant dermatitis from excessive secretions, rectovaginal fistula with cancer, and urethral hair after phalloplasty causing strictures and infection. The main takeaway was that normalizing discussion, obtaining consent, and using an inclusive trauma-informed approach can improve comfort, access, and outcomes for transgender patients with genital skin concerns.

View more

Conclusions

  • Sex and gender should be understood as multidimensional constructs rather than simple binary categories, especially when evaluating genital anatomy and skin disease in transgender and gender-diverse patients.
  • Transgender and gender-diverse patients often avoid discussing genital concerns because of stigma, so clinicians need to proactively invite these conversations and normalize them in routine care.
  • A trauma-informed, consent-based, patient-led approach is essential for genital history-taking and examination, because many transgender patients have significant prior experiences of assault, discrimination, and medical mistreatment.
  • Dermatology visits for transgender patients should prioritize affirming language, visible positioning, explanation before touch, options for chaperones or support people, and immediate stopping if discomfort arises.
  • Gender-affirming surgeries create unique postoperative anatomies that require clinicians to know the reconstructive techniques in order to recognize normal anatomy versus pathology.
  • Common genital dermatoses after gender-affirming surgery include inflammatory conditions, contact dermatitis, lichen sclerosus, infections, warts, and neoplastic disease.
  • HPV-related disease appears to be a frequent and clinically important problem in post-vaginoplasty patients and can present as condyloma that responds to therapies such as imiquimod or cryotherapy.
  • Rare but serious complications such as fistula, ulceration, and squamous cell carcinoma can occur in reconstructed genital tissue, particularly when access to ongoing gynecologic surveillance is limited.
  • Colonic vaginoplasty can improve lubrication through mucus production, but excessive secretion may also cause irritant dermatitis that can sometimes be helped by reducing secretions pharmacologically.
  • In phalloplasty, inadequate or persistent hair in the neourethra can lead to stricture, infection, granuloma, and repeated surgery, making durable preoperative hair removal critical.
  • Dermatologists can play an important preventive role in gender-affirming surgery by coordinating effective permanent hair removal and postoperative skin care with surgical teams.
  • Overall, better outcomes for transgender patients depend on clinicians speaking comfortably and respectfully about genital anatomy, sexual health, and gender identity while providing inclusive, individualized care.
  • Gold et al. Int J Womens Dermatol. 2023.
  • Gallup 2025.
  • Lane et al. Obstet Gynecol. 2022.
  • Grimstad. Gynecologic examination after PIV. Am J Obstet Gynecol 2021.
  • Grimstad et al. Am J Obstet Gynecol. 2021.
  • Grimstad & Lůkennar. In: van Trotsenburg et al (eds). Context, Principles, and Practice of TransGynecology. 2022.#10.1017/9781108899987
  • Scharbaum JP et al. Travel Med Infect Dis. 2019.
  • McMurray SL et al. JAMA Dermatol. 2020.
  • O’Sullivan SO et al. JAMA Dermatol. 2025.
  • Labanca T & Mañero I. Gynecol Oncol Reports. 2017.
  • Matsuki et al. Int J STD AIDS. 2014.
  • Yang et al. Int J STD AIDS. 2009.
  • Bollo et al. Int J STD AIDS. 2018.
  • Bang et al. Transgender Health. 2023.
  • Koch et al., Lasers Med Sci. 2013.